Supply Varicella Vaccine

Supply Varicella Vaccine

The agency may require 250 doses of varicella vaccine for use in a clinical trial. Provision of varicella vaccine

Reference number: BSP 411

Deadline date: 28/02/2012

This deadline is for… Expressions of interest in tendering

Contract value: £0 – £0

Location where the contract is to be carried out: England

Is this suitable for smaller suppliers? Yes

Is this contract suitable for a voluntary, community and social enterprise organisations? No

Name of the buying organisation: Health Protection Agency

 

Description of the contract

The agency may require 250 doses of varicella vaccine for use in a clinical trial. The vaccine: – MUST NOT contain gelatine due to the nature of the clinical trial; – must be licensed in the UK; – must have a shelf life of more than one year. If the agency confirms the requirement, delivery of the vaccines will be needed around 1 April.

 

Documents

 

Classification of the contract

33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents

 

Additional information

 

Who to contact

Contact name Mark Polglase

Address , NW95EQ

Telephone

Extension number:

Fax

Email purchasing@hpa.org.uk

Web address www.hpa.org.uk

 

How to apply

Suppliers interested in tendering for this requirement should contact Mark Polglase at the email address below. All that is required at the moment is: – notification that you would be interested in tendering if the need arises; – confirmation that you can provide a vaccine that does not contain gelatine. PLEASE ENSURE EMAILS ARE MARKED FOR THE ATTENTION OF MARK POLGLASE